David I. Rosenthal

The University of Texas MD Anderson Cancer Center

Papers

Total Citations

H-Index

About

David I. Rosenthal is a leading radiation oncologist whose research focuses on optimizing treatment for head and neck cancers, particularly oropharyngeal squamous cell carcinoma. His major contributions center on evaluating the toxicity and functional outcomes of advanced radiotherapy techniques, including intensity-modulated proton therapy (IMPT). In his highly cited 2019 study, Rosenthal demonstrated that IMPT significantly reduces severe toxicities, such as pharyngeal dysphagia, compared to traditional photon-based therapies, thereby improving patients’ quality of life during and after treatment. This work has influenced clinical protocols and underscored the importance of sparing critical swallowing structures. With over 200 publications and a citation count exceeding 10,000, Rosenthal’s impact is widely recognized. He has also been instrumental in developing evidence-based guidelines for head and neck cancer management and has received multiple awards for his contributions to radiation oncology. His research continues to shape the future of proton therapy, offering patients safer, more effective cancer care.